NASDAQ
12 hours, 42 minutes ago 
WW
Ww International, INC
8-K: WW International Faces Delisting from Nasdaq Amid Chapter 11 Proceedings
WW International (Weight Watchers) receives notice of delisting from Nasdaq following the commencement of voluntary prepackaged Chapter 11 cases.
Worse than expected
 

NASDAQ
2 days, 23 hours ago 
WW
Ww International, INC
8-K: WW International Files for Chapter 11 to Restructure Debt, Aims for Quick Exit
WW International, Inc. initiates a pre-packaged Chapter 11 reorganization to eliminate $1.15 billion in debt and enhance its financial flexibility.

NASDAQ
3 days, 13 hours ago 
WW
Ww International, INC
10-Q: WW International Faces Debt Restructuring Amidst Financial Challenges
WW International is in discussions to restructure its debt and anticipates a prepackaged bankruptcy filing due to financial difficulties and an expected event of default.
Worse than expected
 

NASDAQ
3 days, 13 hours ago 
WW
Ww International, INC
8-K: WW International Announces Q1 2025 Results, Clinical Subscriptions Surge Amid Debt Restructuring
WW International reports a 9.7% revenue decrease in Q1 2025, but sees a 57.1% increase in clinical subscription revenues and is engaged in discussions for a plan of reorganization to significantly reduce debt.
Worse than expected
 

NASDAQ
18 days, 13 hours ago 
WW
Ww International, INC
DEF: WW International Sets Date for 2025 Annual Shareholder Meeting, Outlines Key Proposals
WW International announces its 2025 Annual Meeting of Shareholders to be held virtually on June 6, 2025, featuring proposals for director elections, auditor ratification, and executive compensation approval.

NASDAQ
21 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Michael Amsel Awarded Restricted Stock Units
Chief Marketing Officer Michael Amsel receives 524,109 restricted stock units in WW International, Inc.

NASDAQ
39 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International CEO Tara Comonte Reports Stock Transactions
Tara Comonte, President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on March 27, 2025.

NASDAQ
49 days, 13 hours ago 
WW
Ww International, INC
8-K: WW International Faces Nasdaq Delisting Notice After Share Price Drops Below $1.00
WW International (WeightWatchers) received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, putting its listing at risk.
Worse than expected
 

NASDAQ
67 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International CEO Tara Comonte Reports Stock Transactions
Tara Comonte, President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on February 27, 2025.

NASDAQ
70 days, 21 hours ago 
WW
Ww International, INC
10-K: WW International Reports Fiscal Year 2024 Results: Transformation Efforts Continue Amidst Market Challenges
WW International faces revenue decline due to shifts in consumer behavior and increased competition, but focuses on strategic initiatives and cost management.
Worse than expected
 

NASDAQ
71 days, 12 hours ago 
WW
Ww International, INC
8-K: WW International Announces Mixed Q4 and Full Year 2024 Results; Names Tara Comonte Permanent CEO
WW International reports a decrease in overall subscribers and revenue for Q4 and full year 2024, but sees growth in its clinical subscription business and improved margins.
Worse than expected
 

NASDAQ
95 days, 12 hours ago 
WW
Ww International, INC
8-K: WW International Borrows $121.3 Million Under Revolving Credit Facility
WW International draws down the remaining available amount under its senior secured revolving credit facility to enhance financial flexibility.
Worse than expected
 

NASDAQ
100 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Interim CEO Tara Comonte Reports Stock Transactions
Tara Comonte, Interim President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on January 27, 2025.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director William H. Shrank Acquires Deferred Stock Units
Director William H. Shrank acquired 3,696 deferred stock units in WW International, Inc. on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Acquires Shares Subject to Transfer Restrictions
Tracey D. Brown, a director at WW International, acquired 3,696 shares of common stock subject to transfer restrictions on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Steven Altschuler Reports Acquisition of Deferred Stock Units
Director Steven Altschuler reported the acquisition of 3,696 deferred stock units in WW International, Inc. on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Julie J. Rice Acquires Shares
Julie J. Rice, a director at WW International, acquired 3,696 shares of common stock on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: Thilo Semmelbauer Reports Acquisition of Deferred Stock Units in WW International, Inc.
Director Thilo Semmelbauer acquired 3,696 deferred stock units in WW International, Inc. on December 30, 2024, according to a Form 4 filing.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Julie Bornstein Acquires Shares
Director Julie Bornstein acquired 3,696 shares of WW International, Inc. common stock on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Denis F. Kelly Acquires Deferred Stock Units
Director Denis F. Kelly acquired 3,696 deferred stock units of WW International, Inc. on December 30, 2024.

NASDAQ
129 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Tara Comonte Reports Stock Transactions
Tara Comonte, Interim President and CEO of WW International, reports the acquisition and disposal of company stock and restricted stock units.

NASDAQ
158 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Interim CEO Tara Comonte Reports Stock Transactions
Interim CEO of WW International, Tara Comonte, reports the acquisition and disposal of company stock and restricted stock units.

NASDAQ
163 days, 21 hours ago 
WW
Ww International, INC
8-K: WW International Announces CFO Transition: Heather Stark Departs, Felicia DellaFortuna Appointed
WW International, Inc. has announced a change in its financial leadership, with Heather Stark stepping down as CFO and Felicia DellaFortuna appointed as her successor.

NASDAQ
171 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Corporate Controller Exercises Stock Options and Sells Shares
Nicole Haag, Corporate Controller and Principal Accounting Officer at WW International, exercised stock options and sold a portion of the acquired shares on November 15, 2024.

NASDAQ
171 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International CFO Exercises Stock Options, Acquires Shares
WW International's Chief Financial Officer, Heather Stark, exercised stock options and acquired 1,758 shares of common stock on November 15, 2024.

NASDAQ
184 days, 12 hours ago 
WW
Ww International, INC
10-Q: WW International Reports Q3 Loss Amidst Restructuring and Impairment Charges
WW International reported a net loss for the third quarter of 2024, impacted by significant impairment charges and restructuring costs, despite a slight increase in gross margin.
Worse than expected
 

NASDAQ
184 days, 21 hours ago 
WW
Ww International, INC
8-K: WW International Reports Mixed Q3 Results Amidst Restructuring and Strategic Shifts
WW International's Q3 2024 results show a decline in overall subscribers and revenue, but a significant increase in clinical subscribers and improved adjusted gross margin.
Worse than expected
 

NASDAQ
192 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Interim CEO Tara Comonte Reports Stock Transactions
Interim President and CEO of WW International, Tara Comonte, reports the acquisition and disposal of common stock and restricted stock units on October 27, 2024.

NASDAQ
204 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Haag Reports Stock Transactions
Nicole Haag, Corporate Controller and Principal Accounting Officer of WW International, reports the acquisition and disposal of common stock and restricted stock units on October 15, 2024.

NASDAQ
204 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International CFO Heather Stark Reports Stock Unit Activity
Heather Stark, CFO of WW International, reports the vesting and conversion of restricted stock units into common stock.

NASDAQ
219 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Julie J. Rice Reports Acquisition of Common Stock
Director Julie J. Rice reported acquiring 3,696 shares of WW International, Inc. common stock on September 30, 2024.

NASDAQ
219 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Denis F. Kelly Reports Acquisition of Deferred Stock Units
Director Denis F. Kelly reports acquisition of 3,696 deferred stock units in WW International, Inc.

NASDAQ
219 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director William H. Shrank Reports Acquisition of Deferred Stock Units
Director William H. Shrank reports acquisition of 3,696 deferred stock units in WW International, Inc.

NASDAQ
219 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Acquires Deferred Stock Units
Director Steven Altschuler acquired 3,696 deferred stock units in WW International, Inc. on September 30, 2024.

NASDAQ
219 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Acquires Deferred Stock Units
Thilo Semmelbauer, a director of WW International, acquired 3,696 deferred stock units on September 30, 2024, according to a Form 4 filing with the SEC.

NASDAQ
219 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Acquires Shares in Recent Transaction
A director of WW International, Tracey D. Brown, acquired 3,696 shares of common stock on September 30, 2024.

NASDAQ
219 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Julie Bornstein Reports Acquisition of Common Stock
Julie Bornstein, a director at WW International, acquired 3,696 shares of common stock on September 30, 2024.

NASDAQ
220 days, 13 hours ago 
WW
Ww International, INC
Form 4: Former WW International CEO Sima Sistani Reports Stock Transactions
Sima Sistani, former CEO and director of WW International, reports the disposition of shares and restricted stock units on September 27, 2024.

NASDAQ
220 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Acquires Significant Stock Units Amid Leadership Transition
Tara Comonte, Interim President and CEO of WW International, receives deferred and restricted stock units following her appointment.

NASDAQ
224 days, 21 hours ago 
WW
Ww International, INC
8-K: WeightWatchers Announces Leadership Shakeup: CEO Sima Sistani Departs, Tara Comonte Named Interim CEO
WeightWatchers CEO Sima Sistani has stepped down, with board member Tara Comonte appointed as interim CEO, effective September 27, 2024.

NASDAQ
263 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Receives 35,000 Restricted Stock Units
Nicole Haag, Corporate Controller and Principal Accounting Officer of WW International, Inc., was granted 35,000 restricted stock units on August 15, 2024, which will vest in two equal installments on August 15, 2025, and August 15, 2026.

NASDAQ
274 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Denis F. Kelly Acquires 64,500 Shares
Director Denis F. Kelly of WW International, Inc. (WW) purchased 64,500 shares of common stock at a price of $0.7736 on August 6, 2024.

NASDAQ
274 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International CEO Sima Sistani Acquires 65,000 Shares
WW International's CEO, Sima Sistani, recently purchased 65,000 shares of the company's common stock at an average price of $0.747 per share.

NASDAQ
281 days, 22 hours ago 
WW
Ww International, INC
10-Q: WW International Reports Mixed Q2 Results Amidst Strategic Shift
WW International's second quarter results show a decrease in revenue but an increase in gross margin, alongside a significant impairment charge.
Worse than expected
 

NASDAQ
281 days, 22 hours ago 
WW
Ww International, INC
8-K: WW International Announces Q2 2024 Results and Restructuring Plan
WW International reported a decrease in revenue and subscribers for Q2 2024, while also announcing a restructuring plan aimed at cost savings and operational streamlining.
Worse than expected
 

NASDAQ
310 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director William Shrank Acquires Deferred Stock Units
Director William H. Shrank acquired 3,696 deferred stock units in WW International, Inc. on July 1, 2024, convertible to common stock upon separation from the Board of Directors.

NASDAQ
310 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Acquires Deferred Stock Units
Thilo Semmelbauer, a director at WW International, acquired 3,696 deferred stock units on July 1, 2024, convertible to common stock.

NASDAQ
310 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Julie J. Rice Reports Acquisition of 3,696 Shares
Julie J. Rice, a director at WW International, reported acquiring 3,696 shares of common stock on July 1, 2024.

NASDAQ
310 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Director Denis F. Kelly Acquires Deferred Stock Units
Director Denis F. Kelly acquired 3,696 deferred stock units of WW International, Inc. on July 1, 2024.

NASDAQ
310 days, 13 hours ago 
WW
Ww International, INC
Form 4: Tara Comonte Acquires Deferred Stock Units in WW International, Inc.
Director Tara Comonte acquired 3,696 deferred stock units in WW International, Inc. on July 1, 2024, according to a Form 4 filing.

WW 
Ww International, INC 
NASDAQ

8-K: WW International Announces Q2 2024 Results and Restructuring Plan

Sentiment:
 Quarterly Report
 1 August 2024 7:05 AM

WW International reported a decrease in revenue and subscribers for Q2 2024, while also announcing a restructuring plan aimed at cost savings and operational streamlining.

Worse than expected
  The company's revenue decreased by 10.9% year-over-year, indicating worse than expected performance.  The company's net income decreased by 54.2% year-over-year, indicating worse than expected performance.  The company's total end of period subscribers decreased by 6.1% year-over-year, indicating worse than expected performance. 

Summary
  • WW International, also known as WeightWatchers, announced its financial results for the second quarter of fiscal year 2024, which ended on June 29, 2024.
  • The company reported a revenue of $202.1 million, a decrease of 10.9% compared to the same period last year.
  • Subscription revenues were $200.0 million, down 5.7% year-over-year, while other revenues significantly decreased by 85.6% to $2.1 million due to the discontinuation of the consumer products business.
  • The company's gross margin was 67.9%, up from 63.1% in the prior year period, primarily due to the discontinuation of the lower margin consumer products business.
  • Operating income was $35.9 million, a 36.5% increase compared to the prior year, and adjusted operating income was $37.9 million, a 12.0% increase.
  • Net income was $23.3 million, a decrease of 54.2% compared to the prior year.
  • The company's earnings per share (EPS) was $0.29, down from $0.65 in the prior year.
  • End of period subscribers totaled 3.8 million, a decrease of 6.1% year-over-year, with declines in digital and workshops + digital subscribers, but a significant increase in clinical subscribers.
  • WW International also announced a 2024 restructuring plan expected to result in $100 million of annual run-rate cost savings.
  • The company anticipates recording restructuring charges between $12.0 million and $15.0 million in the second half of fiscal 2024.
  • Full year fiscal 2024 revenue is expected to be at least $770.0 million, and adjusted operating income is expected to be at least $100.0 million.
Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive aspects like improved gross margin and adjusted operating income, but significant negatives such as revenue decline, subscriber losses, and a large drop in net income. The restructuring plan is a necessary step but also indicates underlying issues. Overall, the sentiment is cautiously negative.

Highlights
  • WW International's Q2 2024 revenue was $202.1 million, a 10.9% decrease year-over-year.
  • Subscription revenues decreased by 5.7% to $200.0 million, while other revenues plummeted by 85.6% to $2.1 million.
  • Gross margin improved to 67.9%, up from 63.1% in the prior year period.
  • Operating income increased by 36.5% to $35.9 million, and adjusted operating income increased by 12.0% to $37.9 million.
  • Net income decreased by 54.2% to $23.3 million, and EPS decreased by 54.9% to $0.29.
  • Total end of period subscribers decreased by 6.1% to 3.8 million, with clinical subscribers increasing by 119.8%.
  • The company announced a 2024 restructuring plan expected to yield $100 million in annual cost savings.
  • Restructuring charges are estimated to be between $12.0 million and $15.0 million in the second half of fiscal 2024.
  • Full year fiscal 2024 revenue is expected to be at least $770.0 million, and adjusted operating income is expected to be at least $100.0 million.
Positives
  • Gross margin increased to 67.9% due to the discontinuation of the lower margin consumer products business.
  • Operating income increased by 36.5% to $35.9 million.
  • Adjusted operating income increased by 12.0% to $37.9 million.
  • Clinical subscribers increased by 119.8% year-over-year.
  • The 2024 restructuring plan is expected to result in $100 million of annual run-rate cost savings.
Negatives
  • Total revenue decreased by 10.9% to $202.1 million.
  • Subscription revenues decreased by 5.7% to $200.0 million.
  • Other revenues decreased significantly by 85.6% to $2.1 million.
  • Net income decreased by 54.2% to $23.3 million.
  • Earnings per share decreased by 54.9% to $0.29.
  • Total end of period subscribers decreased by 6.1% to 3.8 million.
  • Digital subscribers decreased by 4.2% and Workshops + Digital subscribers decreased by 21.4%.
Risks
  • The company faces competition from other weight management and health and wellness industry participants.
  • There is a risk of failure to retain and grow the subscriber base.
  • The company may not be able to successfully develop new, innovative services and products.
  • The company's strategic initiatives may not be successfully implemented.
  • There are uncertainties related to a downturn in general economic conditions or consumer confidence.
  • The company has a substantial amount of debt and debt service obligations.
  • There are risks associated with data security breaches and other malicious acts.
  • The company's international operations are subject to regulatory, economic, political, and social risks.
  • The company is exposed to extensive and complex healthcare laws and regulations as a result of the acquisition of Sequence.
Future Outlook

The company expects full year fiscal 2024 revenue to be at least $770.0 million and adjusted operating income to be at least $100.0 million. The restructuring plan is expected to yield $100 million in annual cost savings.

Management Comments
  • Sima Sistani, the company's CEO, stated that WeightWatchers has the right strategy to return the business to growth and is taking decisive actions to navigate the changing landscape.
  • Heather Stark, the company's CFO, mentioned that the company is refining its operational framework and concentrating on high impact initiatives to enhance efficiency, accountability, and speed.
Industry Context

The weight management industry is highly competitive and rapidly evolving, with increasing focus on digital health solutions. WW International is attempting to adapt to these changes by streamlining operations and focusing on its clinical and digital offerings. The company is also facing challenges in retaining and growing its subscriber base, which is a common issue in the subscription-based business model.

Comparison to Industry Standards
  • WW International's revenue decline of 10.9% is concerning compared to some competitors in the digital health space that are experiencing growth.
  • The increase in clinical subscribers by 119.8% is a positive sign, but the overall subscriber base decline of 6.1% indicates a need for improvement in digital and workshop offerings.
  • The company's gross margin of 67.9% is relatively strong, suggesting efficient cost management in its core subscription business.
  • The restructuring plan and cost-saving initiatives are similar to actions taken by other companies in the industry facing similar challenges.
  • Compared to companies like Noom, which focuses on behavioral health and has seen significant growth, WW International needs to demonstrate a stronger ability to innovate and adapt to changing consumer preferences.
  • The company's adjusted operating income increase of 12.0% is a positive sign, but the net income decrease of 54.2% highlights the impact of restructuring and other charges.
Stakeholder Impact
  • Shareholders will be impacted by the decrease in revenue, net income, and EPS, but may see long-term benefits from the restructuring plan.
  • Employees will be impacted by the reduction in force and elimination of certain positions.
  • Customers may experience changes in the company's offerings as a result of the restructuring plan.
  • Suppliers may be impacted by changes in the company's operational structure.
  • Creditors will be impacted by the company's debt and debt service obligations.
Next Steps
  • The company will execute the 2024 restructuring plan, which is expected to be fully completed by the end of fiscal 2025.
  • The company will focus on strategic initiatives to expand care, expand access, and expand payment options for its members.
  • The company will continue to refine its operational framework and concentrate on high impact initiatives to enhance efficiency, accountability, and speed.
Key Dates
  • 2024-06-29: End of the fiscal quarter for which results are reported.
  • 2024-07-27: Date the company committed to the restructuring plan and the date of the earliest event reported.
  • 2024-07-31: Date of the agreement with the departing Chief Technology Officer.
  • 2024-08-01: Date of the press release announcing Q2 2024 results.
  • 2024-08-09: Effective date of the Chief Technology Officer's departure from providing services.
  • 2024-10-31: Effective date of the Chief Technology Officer's termination of employment.
Keywords
WeightWatchers, WW International, restructuring, cost savings, subscribers, revenue, operating income, clinical, digital, financial results

WW 
Ww International, INC 
NASDAQ
Sector: TBD
 
Filings with Classifications
Worse than expected
9 May 2025 5:03 PM

8-K Filing
  • The company received a delisting notice from Nasdaq.
  • The company has commenced voluntary prepackaged cases under chapter 11 of title 11 of the United States Code.
  • Trading of WW International's common stock is expected to be suspended on May 16, 2025.
Worse than expected
6 May 2025 4:13 PM

Quarterly Report
  • The company's financial results were worse than expected due to declining revenues and increasing losses.
  • The company's leverage ratio was worse than required by its debt covenants, leading to an expected event of default.
  • The company's outlook is worse than expected due to the anticipation of a bankruptcy filing.
Worse than expected
6 May 2025 4:03 PM

Earnings Release
  • Overall revenues decreased by 9.7% year-over-year, indicating a decline in the core business.
  • Total subscribers decreased by 14.2% year-over-year, suggesting challenges in retaining and attracting customers.
  • The company is planning a prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code, indicating financial distress.
Worse than expected
21 March 2025 4:05 PM

8-K Filing
  • WW International received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, which is worse than expected.
Worse than expected
28 February 2025 7:14 AM

Annual Results
  • The company's revenue decreased by 11.6% compared to the previous year.
  • The company recorded a net loss of $345.7 million, a significant increase from the net loss of $112.3 million in the previous year.
  • The company's operating loss was $236.2 million, compared to an operating income of $22.3 million in the previous year.
Worse than expected
27 February 2025 4:01 PM

Earnings Release
  • Overall subscriber numbers and total revenues decreased in both Q4 and full year 2024.
  • Digital and Workshops + Digital businesses experienced declines in subscribers and paid weeks.
  • The company reported a significant operating loss for the full year, driven by non-cash impairment charges.
Worse than expected
3 February 2025 4:15 PM

8-K Filing
  • The company needed to draw down the remaining amount of its revolving credit facility, which may indicate financial strain.
Worse than expected
6 November 2024 4:03 PM

Quarterly Report
  • The company's Q3 2024 results were worse than expected due to a significant net loss, a decline in revenue, and substantial impairment charges.
  • The company's net loss for the first nine months of 2024 was significantly worse than the same period in 2023 due to a large impairment charge.
Worse than expected
6 November 2024 7:05 AM

Quarterly Report
  • The company's revenue and overall subscriber numbers were down compared to the prior year, indicating worse than expected results.
Worse than expected
1 August 2024 7:13 AM

Quarterly Report
  • The company's revenue declined by 10.9% in the second quarter and 12.8% for the first six months of 2024, indicating worse than expected performance.
  • The company recorded a significant net loss of $324.6 million for the first six months of 2024, primarily due to a large impairment charge, which is worse than expected.
Worse than expected
1 August 2024 7:05 AM

Quarterly Report
  • The company's revenue decreased by 10.9% year-over-year, indicating worse than expected performance.
  • The company's net income decreased by 54.2% year-over-year, indicating worse than expected performance.
  • The company's total end of period subscribers decreased by 6.1% year-over-year, indicating worse than expected performance.
Worse than expected
24 May 2024 5:15 PM

Amendment to 8-K Filing
  • The proposal to adopt a majority voting standard for uncontested director elections was not approved by shareholders, which is a negative outcome for the company's governance structure.
  • The initial voting results were erroneous, requiring a correction, which reflects poorly on the company's internal processes.
Worse than expected
9 May 2024 5:39 PM

Quarterly Report Amendment
  • The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same period last year.
  • The company's revenue decreased by 14.6%, indicating a worse performance compared to the prior year.
  • The company's operating loss of $269.3 million is significantly worse than the $28.6 million loss in the prior year.
Worse than expected
9 May 2024 4:30 PM

Quarterly Report Amendment
  • The company's revenue decreased by 14.6% year-over-year, indicating a worse performance than expected.
  • The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
  • The company's total end of period subscribers decreased by 0.5% year-over-year, indicating a worse performance than expected.
Worse than expected
2 May 2024 4:09 PM

Quarterly Report
  • The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same quarter last year.
  • The company's revenue decreased by 14.6%, indicating a decline in business performance.
  • The company incurred a $258 million impairment charge on franchise rights, further impacting the financial results.
Worse than expected
2 May 2024 4:05 PM

Quarterly Report
  • The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
  • Subscription revenues decreased by 3.7% on a constant currency basis, indicating a decline in core business performance.
  • Other revenues declined dramatically by 92.0% on a constant currency basis, which is a significant negative impact.
Better than expected
14 March 2024 4:41 PM

Regulation FD Disclosure
  • The company is on track to exceed its previously provided guidance for clinical subscribers, indicating better than expected performance.
Worse than expected
28 February 2024 4:29 PM

Annual Results
  • The company's revenue decreased by 14.5% year-over-year, indicating worse than expected performance.
  • The company's gross profit decreased by 14.8% year-over-year, indicating worse than expected performance.
  • The company's operating income margin decreased by 4.6% year-over-year, indicating worse than expected performance.
Worse than expected
28 February 2024 4:06 PM

Quarterly Report
  • The company's revenue decreased by 7.6% in Q4 2023 and 14.5% for the full year 2023, indicating worse than expected performance.
  • The company reported a net loss of $88.1 million in Q4 2023 and $112.3 million for the full year 2023, which is worse than the prior year.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.